Salivary biomarkers of periodontal disease in response to treatment
- PMID: 21480939
- PMCID: PMC3095429
- DOI: 10.1111/j.1600-051X.2011.01706.x
Salivary biomarkers of periodontal disease in response to treatment
Abstract
Background: Salivary biomarkers of periodontitis were assessed longitudinally to determine response to therapy.
Methods: A 6-month case-controlled study of adults with chronic periodontitis was performed, with 33 participants receiving oral hygiene instructions (OHI) alone and 35 with scaling and root planing (SRP) combined with OHI. Saliva samples collected at week 0, 16 and 28 were analysed for interleukin (IL)-1β, IL-8, macrophage inflammatory protein (MIP)-1α, matrix metalloproteinase-8 (MMP-8), osteoprotegerin (OPG), and tumour necrosis factor-α (TNF)-α. Clinical measures of periodontal disease were recorded at each visit.
Results: All parameters of periodontal health improved significantly in both groups by week 16 (p<0.0001) with the SRP group demonstrating greater benefit at week 16 and 28. Baseline OPG and TNF-α levels changed significantly at both follow-up visits (p<0.03), regardless of treatment group. IL-1β and MMP-8 levels decreased significantly from baseline (p<0.04) in the SRP group only. OPG, MMP-8, and MIP-1α were significantly reduced in responders compared with non-responders (p=0.04, 0.01, 0.05, respectively). In receiver-operating characteristic analyses, MMP-8 produced the highest area under the curve (0.7; p=0.01).
Conclusion: Salivary levels of IL-1β, MMP-8, OPG, and MIP-1α reflected disease severity and response to therapy suggesting their potential utility for monitoring periodontal disease status.
© 2011 John Wiley & Sons A/S.
Conflict of interest statement
The authors report no conflicts of interest related to this study.
Figures



Similar articles
-
Salivary IgA, Interleukin-1β and MMP-8 as Salivary Biomarkers in Chronic Periodontitis Patients.Chin J Dent Res. 2017;20(1):43-51. doi: 10.3290/j.cjdr.a37741. Chin J Dent Res. 2017. PMID: 28232966
-
Salivary biomarkers associated with gingivitis and response to therapy.J Periodontol. 2014 Aug;85(8):e295-303. doi: 10.1902/jop.2014.130696. Epub 2014 Feb 6. J Periodontol. 2014. PMID: 24502627 Free PMC article.
-
Periodontitis and Endothelial Dysfunction: Periodontal Clinical Parameters and Levels of Salivary Markers Interleukin-1β, Tumor Necrosis Factor-α, Matrix Metalloproteinase-2, Tissue Inhibitor of Metalloproteinases-2 Complex, and Nitric Oxide.J Periodontol. 2017 Aug;88(8):778-787. doi: 10.1902/jop.2017.170023. Epub 2017 May 11. J Periodontol. 2017. PMID: 28492359
-
Effect of periodontal therapy on serum and salivary Interleukin-1 beta (IL-1β) and malondialdehyde levels in chronic periodontitis.Cell Mol Biol (Noisy-le-grand). 2024 Nov 24;70(10):167-173. doi: 10.14715/cmb/2024.70.10.22. Cell Mol Biol (Noisy-le-grand). 2024. PMID: 39605109
-
Changes in Inflammatory Cytokines in Saliva after Non-Surgical Periodontal Therapy: A Systematic Review and Meta-Analysis.Int J Environ Res Public Health. 2020 Dec 29;18(1):194. doi: 10.3390/ijerph18010194. Int J Environ Res Public Health. 2020. PMID: 33383828 Free PMC article.
Cited by
-
Diagnostic performance of a point-of-care test device for periodontitis using human saliva: a single-center, single-blinded, confirmatory study.Clin Oral Investig. 2023 Dec 26;28(1):27. doi: 10.1007/s00784-023-05443-y. Clin Oral Investig. 2023. PMID: 38147192
-
Characterizing the Subgingival Microbiome of Pregnant African American Women.J Obstet Gynecol Neonatal Nurs. 2019 Mar;48(2):140-152. doi: 10.1016/j.jogn.2018.12.003. Epub 2018 Dec 28. J Obstet Gynecol Neonatal Nurs. 2019. PMID: 30597136 Free PMC article.
-
Short-term effect of non-surgical periodontal treatment on local and systemic cytokine levels: Role of hyperglycemia.Cytokine. 2021 Feb;138:155360. doi: 10.1016/j.cyto.2020.155360. Epub 2020 Nov 19. Cytokine. 2021. PMID: 33221157 Free PMC article. Clinical Trial.
-
Plasmonic Optical Fibre-Based Point-of-Care Test for Periodontal MIP-1α Detection: A Validation Study of a Multiplexed Biosensor Prototype.Int Dent J. 2025 Aug;75(4):100830. doi: 10.1016/j.identj.2025.04.010. Epub 2025 Jun 2. Int Dent J. 2025. PMID: 40460515 Free PMC article.
-
Minireview on the Connections between the Neuropsychiatric and Dental Disorders: Current Perspectives and the Possible Relevance of Oxidative Stress and Other Factors.Oxid Med Cell Longev. 2020 Jun 30;2020:6702314. doi: 10.1155/2020/6702314. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32685098 Free PMC article. Review.
References
-
- Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4:1–6. - PubMed
-
- Armitage GC. Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000. 2004;34:9–21. - PubMed
-
- Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature. 1986;319:516–518. - PubMed
-
- Buduneli N, Biyikoğlu B, Sherrabeh S, Lappin DF. Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients. J Clin Periodontol. 2008;35:846–852. - PubMed
-
- Choi SJ, Cruz JC, Craig F, Chung H, Devlin RD, Roodman GD, Alsina M. Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood. 2000;96:671–675. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical